Reaction Details |
| Report a problem with these data |
Target | Beta-2 adrenergic receptor |
---|
Ligand | BDBM50313949 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_615505 (CHEMBL1105983) |
---|
IC50 | >20000±n/a nM |
---|
Citation | Goble, SD; Wang, L; Howell, KL; Bansal, A; Berger, R; Brockunier, L; DiSalvo, J; Feighner, S; Harper, B; He, J; Hurley, A; Hreniuk, D; Parmee, E; Robbins, M; Salituro, G; Sanfiz, A; Streckfuss, E; Watkins, E; Weber, AE; Struthers, M; Edmondson, SD Heterocyclic acetamide and benzamide derivatives as potent and selective beta3-adrenergic receptor agonists with improved rodent pharmacokinetic profiles. Bioorg Med Chem Lett20:1895-9 (2010) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Beta-2 adrenergic receptor |
---|
Name: | Beta-2 adrenergic receptor |
Synonyms: | ADRB2 | ADRB2R | ADRB2_HUMAN | B2AR | Beta-2 adrenoceptor | Beta-2 adrenoreceptor |
Type: | n/a |
Mol. Mass.: | 46461.69 |
Organism: | Homo sapiens (Human) |
Description: | P07550 |
Residue: | 413 |
Sequence: | MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAK
FERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTAS
IETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQE
AINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRF
HVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQD
NLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNT
GEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL
|
|
|
BDBM50313949 |
---|
n/a |
---|
Name | BDBM50313949 |
Synonyms: | (R)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-N-(4-(2-(2-hydroxy-2-(pyridin-3-yl)ethylamino)ethyl)phenyl)acetamide | CHEMBL1090416 |
Type | Small organic molecule |
Emp. Form. | C22H27N5O2 |
Mol. Mass. | 393.4821 |
SMILES | Cc1cc(C)n(CC(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)n1 |r| |
Structure |
|